Identification of three novel LRRK2 mutations associated with Parkinson's disease in a calabrian population

Journal of Alzheimer's Disease

Volumn 38, Issue 2, 2014, Pages 351-357

  Anfossi, Maria ^a   Colao, Rosanna ^a   Gallo, Maura ^a   Bernardi, Livia ^a   Conidi, M Elena ^a   Frangipane, Francesca ^a   Vasso, Franca ^a   Puccio, Gianfranco ^a   Clodomiro, Alessandra ^a   Mirabelli, Maria ^a   Curcio, Sabrina A M ^a   Torchia, Giusi ^a   Smirne, Nicoletta ^a   Di Lorenzo, Raffaele ^a   Maletta, Raffaele ^a   Bruni, Amalia C ^a  

^a Centro Regionale di Neurogenetica   (Italy)

Author keywords

Dementia; frequency mutations; genetics association; LRRK2; neurodegenerative disease; Parkinson's disease

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ADULT; AGED; ARTICLE; BRADYKINESIA; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; EXON; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENE MUTATION; GENETIC IDENTIFICATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; LOWER PLEISTOCENE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; TREMOR;

DEMENTIA; FREQUENCY MUTATIONS; GENETICS ASSOCIATION; LRRK2; NEURODEGENERATIVE DISEASE; PARKINSON'S DISEASE;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HUMANS; ITALY; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; POPULATION GROUPS; PROTEIN-SERINE-THREONINE KINASES; SEVERITY OF ILLNESS INDEX;

EID: 84889602366     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130689     Document Type: Article

References (29)

1. Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson's disease. Ann Rev Neurosci 28, 57-87. (Pubitemid 41098899)
2. Zimprich A, Biskup S, Leitner P Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, M̈uller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607. (Pubitemid 39531225)
3. Hedrich K, Winkler S, Hagenah J, Kabakci K, Kasten M, Schwinger E, Volkmann J, Pramstaller PP, Kostic V, Vieregge P, Klein C (2006) Recurrent LRRK2 (Park8) mutations in early-onset Parkinson's disease. Mov Disord 21, 1506-1510. (Pubitemid 44613312)
4. Bosgraaf L, Van Haastert PJ (2003) Roc, a Ras/GTPase domain in complex proteins. Biochim Biophys Acta 1643, 5-10. (Pubitemid 37494887)
5. Cookson MR (2010) The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat Rev Neurosci 11, 791-797.
6. MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, AbeliovichA(2006) The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52, 587-593. (Pubitemid 44781171)
7. Paiśan-Ruiz C,Washecka N, Nath P, Singleton AB, CorderEH (2009) Parkinson's disease and low frequency alleles found together throughout LRRK2. Ann Hum Genet 73, 391-403.
8. Nuytemans K, Theuns, J, Van Broeckhoven C, Parkinson Disease Mutation Database, http://www.molgen.ua.ac.be/PDmutDB.
9. Zabetian CP, Hutter CM, Yearout D, Lopez AN, Factor SA, Griffith A, Leis BC, Bird TD, Nutt JG, Higgins DS, Roberts JW, Kay DM, Edwards KL, Samii A, Payami H (2006) LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: Evidence of two distinct founding events beginning two millennia ago. Am J Hum Genet 79, 752-758. (Pubitemid 44452754)
10. Lesage S, Durr A, Tazir M, Lohmann E, Leutenegger AL, Janin S, Pollak P, Brice A, French Parkinson's Disease Genetics Study, Group (2006) LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 354, 422-423. (Pubitemid 43145082)
11. Klein C, Lohmann-HedrichK(2007) Impact of recent genetic findings in Parkinson's disease. Curr Opin Neurol 20, 453-464. (Pubitemid 47051994)
12. Di Fonzo A, Rohe CF, Ferreira J, Chien HF, Vacca L, Stocchi F, Guedes L, Fabrizio E, Manfredi M, Vanacore N, Goldwurm S, Breedveld G, Sampaio C, Meco G, Barbosa E, Oostra BA, Bonifati V; Italian Parkinson Genetics Network (2005) A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365, 412-415. (Pubitemid 40179228)
13. Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H, Tsuji S, Obata F (2005) An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 57, 918-921. (Pubitemid 40798631)
14. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55, 181-184.
15. Hoehn MM, Yahr MD (1967) Parkinsonism: Onset, progression, and mortality. Neurology 5, 427-442.
16. Fahn S, Elton R, Members of the UPDRS Development Committee (1987) The unified Parkinson disease rating scale. In Recent Developments in Parkinson's Disease, Vol, 2, Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Macmillan Health Care Information, Florham Park, NJ, pp. 153-163 and 293-304.
17. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
18. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 44, 2308-2314. (Pubitemid 24382728)
19. Berg D, Schweitzer KJ, Leitner P (2005) Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease. Brain 128, 3000-3011.
20. PolyPhen-2, Prediction of Functional Effects of Human nsSNPs, http://genetics.bwh.harvard.edu/pph2/index.shtml.
21. De Rosa A, Criscuolo C, Mancini P, De Martino M, Giordano IA, Pappat̀a S, Filla A, De Michele G (2009) Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy. Parkinsonism Relat Disord 15, 242-244.
22. Mata IF, Taylor JP, Kachergus J, Hulihan M, Huerta C, Lahoz C, Blazquez M, Guisasola LM, Salvador C, Ribacoba R, Martinez C, Farrer M, Alvarez V (2005) LRRK2 R1441G in Spanish patients with Parkinson's disease. Neurosci Lett 382, 309-311. (Pubitemid 40733642)
23. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA Salmon DP, Lowe J,Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus Guidelines International Workshop for the clinical and pathological diagnosis of dementia with Lewy body disease (DLB): Report of the consortium on DLB. Neurology 47, 1113-1124. (Pubitemid 26374873)
24. Gaig C, Ezquerra M, Marti MJ, Muñoz E, Valldeoriola F, Tolosa E (2006) LRRK2 mutations in Spanish patients with Parkinson disease: Frequency, clinical features, and incomplete penetrance. Arch Neurol 63, 377-382.
25. Ishihara L, Warren L, Gibson R, Amouri R, Lesage S, D̈urr A, Tazir M, Wszolek ZK, Uitti RJ, Nichols WC, Griffith A, Hattori N, Leppert D, Watts R, Zabetian CP, Foroud TM, Farrer MJ, Brice A, Middleton L, Hentati F (2006) Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. Arch Neurol 63, 1250-1254. (Pubitemid 44379825)
26. Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M (2010) Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis. Neurology 75, 1062-1069.
27. Marras C, Scḧule B, Munhoz RP, Rogaeva E, Langston JW, Kasten M, Meaney C, Klein C, Wadia PM, Lim SY, Chuang RS, Zadikof C, Steeves T, Prakash KM, de Bie RM, Adeli G, Thomsen T, Johansen KK, Teive HA, Asante A, Reginold W, Lang AE (2011) Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology 77, 325-333.
28. Mirelman A, Gurevich T, Giladi N, Bar-Shira A, Orr-Urtreger A, Hausdorff JM (2011) Gait alterations in healthy carriers of the LRRK2 G2019S mutation. Ann Neurol 69, 193-197.
29. Alcalay RN, Mejia-Santana H, Tang MX, Rosado L, VerbitskyM, Kisselev S, Ross BM, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, Mickel SF, Andrews HF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Siderowf A, Caccappolo E, Ottman R, Clark LN, Marder KS (2009) Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol 66, 1517-1522.